Oral dna vaccine composition for hepatitis b virus chronic...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/711 (2006.01) A61K 39/29 (2006.01) C12N 5/10 (2006.01) C12N 15/40 (2006.01) C12N 15/51 (2006.01)

Patent

CA 2380471

The present invention provides an oral DNA composition for improving an impaired immunity associated with chronic infection of hepatitis B virus (HBV) comprising an attenuated strain of bacterial cells which preferentially target phagocytic cells of the intestinal mucosa, and which serve as a vehicle for a plasmid vector carrying one or more genes or complementary DNA coding for at least a portion of a hepatitis B viral protein or peptide. Given orally, the DNA composition causes a transient and self-limiting infection of the intestinal tract through autolysis of the bacterial cells and release of the plasmid after gaining entry into infected host cells. A promotor contained within the plasmid allows for expression of the HBV gene(s) in the eurokaryotic environment, the viral products of which help to booster a cell- mediated immunity to clear the infection and reverse a state of immune tolerance characteristic of HBV chronic infection.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Oral dna vaccine composition for hepatitis b virus chronic... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Oral dna vaccine composition for hepatitis b virus chronic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Oral dna vaccine composition for hepatitis b virus chronic... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1784998

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.